In­sil­i­co finds a new part­ner for AI drug dis­cov­ery; EU launch­es Il­lu­mi­na probe af­ter Grail merg­er close

Hot off a $255 mil­lion megaround, Chi­nese AI start­up In­sil­i­co Med­i­cine has found its lat­est part­ner.

In­sil­i­co is join­ing hands with Shang­hai-based BioNo­va Phar­ma­ceu­ti­cals to joint­ly de­vel­op small mol­e­cule in­hibitors for hema­to­log­ic ma­lig­nan­cies. Though they’re not re­leas­ing the fi­nan­cial terms of the deal, the part­ners said they’re kick­ing things off with a dis­cov­ery-stage project from BioNo­va.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER